CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Angiotensin–neprilysin inhibition versus enalapril in heart failure Management of left main disease: an update Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients Right ventricular function and outcome in patients undergoing transcatheter aortic valve replacement Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population

Clinical Trial2014 Sep 11;371(11):993-1004.

JOURNAL:N Engl J Med. Article Link

Angiotensin–neprilysin inhibition versus enalapril in heart failure

McMurray JJ, Packer M, PARADIGM-HF Investigators and Committees. Keywords: angiotensin receptor-neprilysin inhibitor LCZ696; enalapril; HFrEF; mortality; survival; hospitalization for heart failure

FULL TEXT PDF